I'm predicting Regeneron's mab is next to get EUA.

I'm predicting Regeneron's mab is next to get EUA. This will be great news for CYDY. First, it won't compete with leronlimab's action in s/c population. Second, it actually opens the door for leronlimab to also apply for EUA in m/m population as there is no credible excuse left for the FDA to deny Cytodyn. If I were NP, I would apply immediately (as in file for approval not just request opinion) because the climate has changed since we completed CD10. There is nothing to lose and much to gain.